The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Interleukin‐33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells
Abstract
The role of IL‐33/ST2 pathway in antitumor immunity is unclear. Using 4T1 breast cancer model we demonstrate time‐dependent increase of endogenous IL‐33 at both the mRNA and protein levels in primary tumors and metastatic lungs during cancer progression. Administration of IL‐33 accelerated tumor growth and development of lung and liver metastases, which was associated with increased intratumoral accumulation of CD11b+Gr‐1+ TGF‐β1+ myeloid‐derived suppressor cells (MDSCs) that expressed IL‐13α1R, IL‐13‐producing Lin−Sca‐1+ST2+ innate lymphoid cells (ILCs) and CD4+Foxp3+ST2+IL‐10+ Tregs compared to untreated mice. Higher incidence of monocytic vs. granulocytic MDSCs and plasmocytoid vs. conventional dendritic cells (DCs) was present in mammary tumors of IL‐33‐treated mice. Intratumoral NKp46+NKG2D+ and NKp46+FasL+ cells were markedly reduced after IL‐33 treatment, while phosphate‐buffered saline‐treated ST2‐deficient mice had increased frequencies of these tumoricidal natural killer (NK) cells compared to untreated wild‐type mice. IL‐33 promoted intratumoral cell proliferation and neovascularization, which was attenuated in the absence of ST2. Tumor‐bearing mice given IL‐33 had increased percentages of splenic MDSCs, Lin−Sca‐1+ ILCs, IL‐10‐expressing CD11c+ DCs and alternatively activated M2 macrophages and higher circulating levels of IL‐10 and IL‐13. A significantly reduced NK cell, but not CD8+ T‐cell cytotoxicity in IL‐33‐treated mice was observed and the mammary tumor progression was not affected when CD8+ T cells were in vivo depleted. We show a previously unrecognized role for IL‐33 in promoting breast cancer progression through increased intratumoral accumulation of immunosuppressive cells and by diminishing innate antitumor immunity. Therefore, IL‐33 may be considered as an important mediator in the regulation of breast cancer progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Schmitz, J., Owyang, A., Oldham, E., Song, Y., Murphy, E., McClanahan, T. K., Zurawski, G., Moshrefi, M., Qin, J., Li, X., et al. (2005) · Immunity · doi:10.1016/j.immuni.2005.09.015 · Cited by 3,710
Innate production of TH2 cytokines by adipose tissue-associated c-Kit+Sca-1+ lymphoid cells
Moro, K., Yamada, T., Tanabe, M., Takeuchi, T., Ikawa, T., Kawamoto, H., Furusawa, J.-I., Ohtani, M., Fujii, H., & Koyasu, S. (2010) · Nature · doi:10.1038/nature08636 · Cited by 1,992
Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity
Neill, D. R., Wong, S. H., Bellosi, A., Flynn, R. J., Daly, M., Langford, T. K. A., Bucks, C., Kane, C. M., Fallon, P. G., Pannell, R., et al. (2010) · Nature · doi:10.1038/nature08900 · Cited by 1,938
Subsets of Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice
Youn, J.-I., Nagaraj, S., Collazo, M., & Gabrilovich, D. I. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.8.5791 · Cited by 1,645
Huang, B., Pan, P.-Y., Li, Q., Sato, A. I., Levy, D. E., Bromberg, J., Divino, C. M., & Chen, S.-H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1299 · Cited by 1,435
Akbari, O., DeKruyff, R. H., & Umetsu, D. T. (2001) · Nature Immunology · doi:10.1038/90667 · Cited by 1,205
Disease-associated functions of IL-33: the new kid in the IL-1 family
Liew, F. Y., Pitman, N. I., & McInnes, I. B. (2010) · Nature Reviews Immunology · doi:10.1038/nri2692 · Cited by 1,003
Proliferation Marker Ki-67 in Early Breast Cancer
Urruticoechea, A., Smith, I. E., & Dowsett, M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.07.501 · Cited by 837
CD4 and CD8 Expression by Dendritic Cell Subtypes in Mouse Thymus and Spleen
Vremec, D., Pooley, J., Hochrein, H., Wu, L., & Shortman, K. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.6.2978 · Cited by 811
Halim, T. Y. F., Krauß, R. H., Sun, A. C., & Takei, F. (2012) · Immunity · doi:10.1016/j.immuni.2011.12.020 · Cited by 804
Kurowska-Stolarska, M., Stolarski, B., Kewin, P., Murphy, G., Corrigan, C. J., Ying, S., Pitman, N., Mirchandani, A., Rana, B., van Rooijen, N., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901575 · Cited by 717
The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1
Cayrol, C., & Girard, J.-P. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812690106 · Cited by 707
IL-33 is a crucial amplifier of innate rather than acquired immunity
Oboki, K., Ohno, T., Kajiwara, N., Arae, K., Morita, H., Ishii, A., Nambu, A., Abe, T., Kiyonari, H., Matsumoto, K., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003059107 · Cited by 652
IL-33 reduces the development of atherosclerosis
Miller, A. M., Xu, D., Asquith, D. L., Denby, L., Li, Y., Sattar, N., Baker, A. H., McInnes, I. B., & Liew, F. Y. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071868 · Cited by 642
Löhning, M., Stroehmann, A., Coyle, A. J., Grogan, J. L., Lin, S., Gutierrez-Ramos, J.-C., Levinson, D., Radbruch, A., & Kamradt, T. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.6930 · Cited by 605
Gabitass, R. F., Annels, N. E., Stocken, D. D., Pandha, H. A., & Middleton, G. W. (2011) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-011-1028-0 · Cited by 575
IL-1 Receptor Accessory Protein and ST2 Comprise the IL-33 Receptor Complex
Chackerian, A. A., Oldham, E. R., Murphy, E. E., Schmitz, J., Pflanz, S., & Kastelein, R. A. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.4.2551 · Cited by 508
Townsend, M. J., Fallon, P. G., Matthews, D. J., Jolin, H. E., & McKenzie, A. N. J. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.6.1069 · Cited by 482
The parallel lives of angiogenesis and immunosuppression: cancer and other tales
Motz, G. T., & Coukos, G. (2011) · Nature Reviews Immunology · doi:10.1038/nri3064 · Cited by 481
IL-33 exacerbates antigen-induced arthritis by activating mast cells
Xu, D., Jiang, H.-R., Kewin, P., Li, Y., Mu, R., Fraser, A. R., Pitman, N., Kurowska-Stolarska, M., McKenzie, A. N. J., McInnes, I. B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801898105 · Cited by 464
Kurowska-Stolarska, M., Kewin, P., Murphy, G., Russo, R. C., Stolarski, B., Garcia, C. C., Komai-Koma, M., Pitman, N., Li, Y., McKenzie, A. N. J., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.7.4780 · Cited by 460
The Alarmin Interleukin-33 Drives Protective Antiviral CD8 + T Cell Responses
Bonilla, W. V., Fröhlich, A., Senn, K., Kallert, S., Fernandez, M., Johnson, S., Kreutzfeldt, M., Hegazy, A. N., Schrick, C., Fallon, P. G., et al. (2012) · Science · doi:10.1126/science.1215418 · Cited by 417
IL-18 Induces PD-1–Dependent Immunosuppression in Cancer
Terme, M., Ullrich, E., Aymeric, L., Meinhardt, K., Desbois, M., Delahaye, N., Viaud, S., Ryffel, B., Yagita, H., Kaplanski, G., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0993 · Cited by 376
Bourgeois, E., Van, L. P., Samson, M., Diem, S., Barra, A., Roga, S., Gombert, J., Schneider, E., Dy, M., Gourdy, P., et al. (2009) · European Journal of Immunology · doi:10.1002/eji.200838575 · Cited by 329
Interleukin-33 Induces Protective Effects in Adipose Tissue Inflammation During Obesity in Mice
Miller, A. M., Asquith, D. L., Hueber, A. J., Anderson, L. A., Holmes, W. M., McKenzie, A. N., Xu, D., Sattar, N., McInnes, I. B., & Liew, F. Y. (2010) · Circulation Research · doi:10.1161/circresaha.110.218867 · Cited by 324
Elkabets, M., Ribeiro, V. S. G., Dinarello, C. A., Ostrand‐Rosenberg, S., Di Santo, J. P., Apte, R. N., & Vosshenrich, C. A. J. (2010) · European Journal of Immunology · doi:10.1002/eji.201041037 · Cited by 319
Ikutani, M., Yanagibashi, T., Ogasawara, M., Tsuneyama, K., Yamamoto, S., Hattori, Y., Kouro, T., Itakura, A., Nagai, Y., Takaki, S., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101270 · Cited by 314
Breast Cancer Lung Metastasis Requires Expression of Chemokine Receptor CCR4 and Regulatory T Cells
Olkhanud, P. B., Baatar, D., Bodogai, M., Hakim, F., Gress, R., Anderson, R. L., Deng, J., Xu, M., Briest, S., & Biragyn, A. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4619 · Cited by 312
Choi, Y.-S., Choi, H.-J., Min, J.-K., Pyun, B.-J., Maeng, Y.-S., Park, H., Kim, J., Kim, Y.-M., & Kwon, Y.-G. (2009) · Blood · doi:10.1182/blood-2009-02-203372 · Cited by 302
Interleukin 33 as a Mechanically Responsive Cytokine Secreted by Living Cells
Kakkar, R., Hei, H., Dobner, S., & Lee, R. T. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.298703 · Cited by 297
Turnquist, H. R., Zhao, Z., Rosborough, B. R., Liu, Q., Castellaneta, A., Isse, K., Wang, Z., Lang, M., Beer Stolz, D., Zheng, X. X., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100519 · Cited by 245
Independent prognostic value of eosinophil and mast cell infiltration in colorectal cancer tissue
Nielsen, H. J., Hansen, U., Christensen, I. J., Reimert, C. M., Br�nner, N., Moesgaard, F., & The RANX05 Study Group (1999) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199912)189:4<487::aid-path484>3.0.co;2-i · Cited by 233
The critical role of Th1-dominant immunity in tumor immunology
Nishimura, T., Nakui, M., Sato, M., Iwakabe, K., Kitamura, H., Sekimoto, M., Ohta, A., Koda, T., & Nishimura, S. (2000) · Cancer Chemotherapy and Pharmacology · doi:10.1007/pl00014051 · Cited by 211
Impact of FASL-induced apoptosis in the elimination of tumor cells by NK cells
Screpanti, V., Wallin, R. P. A., Grandien, A., & Ljunggren, H.-G. (2005) · Molecular Immunology · doi:10.1016/j.molimm.2004.07.033 · Cited by 172
Tumour‐associated tissue eosinophilia as a prognostic factor in oral squamous cell carcinomas
Dorta, R. G., Landman, G., Kowalski, L. P., Lauris, J. R. P., Latorre, M. R. D. O., & Oliveira, D. T. (2002) · Histopathology · doi:10.1046/j.1365-2559.2002.01437.x · Cited by 161
Type 2 innate immune responses and the natural helper cell
Koyasu, S., & Moro, K. (2011) · Immunology · doi:10.1111/j.1365-2567.2011.03413.x · Cited by 155
Protective role of IL-33/ST2 axis in Con A-induced hepatitis
Volarević, V., Mitrović, M. M., Milovanović, M., Zelen, I., Nikolić, I., Mitrović, S., Pejnovic, N. N., Arsenijević, N., & Lukić, M. L. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.03.022 · Cited by 154
Self-citationTumor associated regulatory dendritic cells
Ma, Y., Shurin, G. V., Gutkin, D. W., & Shurin, M. R. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.02.010 · Cited by 138
Gao, K., Li, X., Zhang, L., Bai, L., Dong, W., Gao, K., Shi, G., Xia, X., Wu, L., & Zhang, L. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.03.002 · Cited by 135
ST2 deletion enhances innate and acquired immunity to murine mammary carcinoma
Jovanović, I., Radosavljevic, G. D., Mitrović, M., Lisnić, V. J., McKenzie, A. N. J., Arsenijević, N., Jonjić, S., & Lukić, M. L. (2011) · European Journal of Immunology · doi:10.1002/eji.201141417 · Cited by 131
Self-citationSerum Interleukin-33 Levels in Patients with Gastric Cancer
Sun, P., Ben, Q., Tu, S., Dong, W., Qi, X., & Wu, Y. (2011) · Digestive Diseases and Sciences · doi:10.1007/s10620-011-1760-5 · Cited by 130
Full-Length IL-33 Promotes Inflammation but not Th2 Response In Vivo in an ST2-Independent Fashion
Luzina, I. G., Pickering, E. M., Kopach, P., Kang, P. H., Lockatell, V., Todd, N. W., Papadimitriou, J. C., McKenzie, A. N. J., & Atamas, S. P. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200259 · Cited by 107
Natural killer cell–dendritic cell crosstalk in the initiation of immune responses
Walzer, T., Dalod, M., Vivier, É., & Zitvogel, L. (2005) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.5.1.s49 · Cited by 104
Kim, R., Emi, M., & Tanabe, K. (2006) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2006.03215.x · Cited by 79
Milovanović, M., Volarević, V., Ljujić, B., Radosavljevic, G. D., Jovanović, I., Arsenijević, N., & Lukić, M. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045225 · Cited by 70
Self-citationGuédez, L., Jensen-Taubman, S., Bourboulia, D., Kwityn, C., Wei, B., Caterina, J. J., & Stetler‐Stevenson, W. G. (2012) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3182619c8e · Cited by 64
IL‐33 promotes DC development in BM culture by triggering GM‐CSF production
Mayuzumi, N., Matsushima, H., & Takashima, A. (2009) · European Journal of Immunology · doi:10.1002/eji.200939472 · Cited by 62
Significance of combination therapy of zoledronic acid and gemcitabine on pancreatic cancer
Zhao, M., Tominaga, Y., Ohuchida, K., Mizumoto, K., Cui, L., Kozono, S., Fujita, H., Maeyama, R., Toma, H., & Tanaka, M. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.02113.x · Cited by 31
Immature tumor angiogenesis in high-grade and high-stage renal cell carcinoma
Kinouchi, T., Mano, M., Matsuoka, I., Kodama, S., Aoki, T., Okamoto, M., Yamamura, H., Usami, M., & Takahashi, K. (2003) · Urology · doi:10.1016/s0090-4295(03)00512-0 · Cited by 27
Cited by
The Tumor Microenvironment Innately Modulates Cancer Progression
Hinshaw, D. C., & Shevde, L. A. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3962 · Cited by 3,270
Natural killer cells and other innate lymphoid cells in cancer
Chiossone, L., Dumas, P.-Y., Vienne, M., & Vivier, E. (2018) · Nature Reviews Immunology · doi:10.1038/s41577-018-0061-z · Cited by 1,007
Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis
Klose, C. S. N., & Artis, D. (2016) · Nature Immunology · doi:10.1038/ni.3489 · Cited by 951
E-cadherin is required for metastasis in multiple models of breast cancer
Padmanaban, V., Krol, I., Suhail, Y., Szczerba, B. M., Aceto, N., Bader, J. S., & Ewald, A. J. (2019) · Nature · doi:10.1038/s41586-019-1526-3 · Cited by 822
Interleukin-33 in tissue homeostasis, injury, and inflammation
Molofsky, A. B., Savage, A. K., & Locksley, R. M. (2015) · Immunity · doi:10.1016/j.immuni.2015.06.006 · Cited by 638
Metadata
- Authors
- Jovanovic, I. P., Pejnovic, N. N., Radosavljevic, G. D., Pantic, J. M., Milovanovic, M. Z., Arsenijevic, N. N., & Lukic, M. L.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2013-10-10
- Volume
- 134
- Issue
- 7
- Pages
- 1669-1682
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W1948324417
- Cited by
- 328
- References
- 50
- FWCI
- 9.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.